SWI Susceptibility Vessel Sign in Patients Undergoing Mechanical Thrombectomy for Acute Ischemic Stroke

References

1. 1.↵
   1. Flacke S,
   2. Urbach H,
   3. Keller E, et al

   . Middle cerebral artery (MCA) susceptibility sign at susceptibility-based perfusion MR imaging: clinical importance and comparison with hyperdense MCA sign at CT. Radiology 2000;215:476–82 doi:10.1148/radiology.215.2.r00ma09476 pmid:10796928

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Schellinger PD,
   2. Chalela JA,
   3. Kang DW, et al

   . Diagnostic and prognostic value of early MR imaging vessel signs in hyperacute patients with stroke imaged <3 hours and treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 2005;26:618–24 pmid:15764589

   PubMedWeb of Science
3. 3.↵
   1. Cho KH,
   2. Kim JS,
   3. Kwon SU, et al

   . Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes. Stroke 2005;36:2379–83 doi:10.1161/01.STR.0000185932.73486.7a pmid:16224077

   Abstract/FREE Full Text
4. 4.↵
   1. Allibert R,
   2. Billon Grand C,
   3. Vuillier F, et al

   . Advantages of susceptibility-weighted magnetic resonance sequences in the visualization of intravascular thrombi in acute ischemic stroke. Int J Stroke 2014;9:980–84 doi:10.1111/ijs.12373 pmid:25319168

   CrossRefPubMed
5. 5.↵
   1. Kim SK,
   2. Yoon W,
   3. Kim TS, et al

   . Histologic analysis of retrieved clots in acute ischemic stroke: correlation with stroke etiology and gradient-echo MRI. AJNR Am J Neuroradiol 2015;36:1756–62 doi:10.3174/ajnr.A4402 pmid:26159515

   Abstract/FREE Full Text
6. 6.↵
   1. Liebeskind DS,
   2. Sanossian N,
   3. Yong WH, et al

   . CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke 2011;42:1237–43 doi:10.1161/STROKEAHA.110.605576 pmid:21393591

   Abstract/FREE Full Text
7. 7.↵
   1. Powers WJ,
   2. Derdeyn CP,
   3. Biller J, et al

   ; American Heart Association Stroke Council. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients with Acute Ischemic Stroke Regarding Endovascular Treatment: a Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke 2015;46:3020–35 doi:10.1161/STR.0000000000000074 pmid:26123479

   Abstract/FREE Full Text
8. 8.↵
   1. Kimura K,
   2. Iguchi Y,
   3. Shibazaki K, et al

   . M1 susceptibility vessel sign on T2* as a strong predictor for no early recanalization after IV-t-PA in acute ischemic stroke. Stroke 2009;40:3130–32 doi:10.1161/STROKEAHA.109.552588 pmid:19556532

   Abstract/FREE Full Text
9. 9.↵
   1. Kang DW,
   2. Jeong HG,
   3. Kim DY, et al

   . Prediction of stroke subtype and recanalization using susceptibility vessel sign on susceptibility-weighted magnetic resonance imaging. Stroke 2017;48:1554–59 doi:10.1161/STROKEAHA.116.016217 pmid:28432264

   Abstract/FREE Full Text
10. 10.↵
    1. Bourcier R,
    2. Mazighi M,
    3. Labreuche J, et al

    ; ASTER Trial Investigators. Susceptibility vessel sign in the ASTER trial: Higher recanalization rate and more favourable clinical outcome after first line stent retriever compared to contact aspiration. J Stroke 2018;20:268–76 doi:10.5853/jos.2018.00192 pmid:29886714

    CrossRefPubMed
11. 11.↵
    1. Darcourt J,
    2. Withayasuk P,
    3. Vukasinovic I, et al

    . Predictive value of susceptibility vessel sign for arterial recanalization and clinical improvement in ischemic stroke. Stroke 2019;50:512–15 doi:10.1161/STROKEAHA.118.022912 pmid:30602358

    CrossRefPubMed
12. 12.↵
    1. Soize S,
    2. Batista AL,
    3. Rodriguez Regent C, et al

    . Susceptibility vessel sign on T2* magnetic resonance imaging and recanalization results of mechanical thrombectomy with stent retrievers: a multicentre cohort study. Eur J Neurol 2015;22:967–72 doi:10.1111/ene.12693 pmid:25786977

    CrossRefPubMed
13. 13.↵
    1. Van Der Marel K,
    2. Chueh J-Y,
    3. Brooks OW, et al

    . Quantitative assessment of device-clot interaction for stent retriever thrombectomy. J Neurointerv Surg 2016;8:1278–82 doi:10.1136/neurintsurg-2015-012209 pmid:26833539

    Abstract/FREE Full Text
14. 14.↵
    1. Yuki I,
    2. Kan I,
    3. Vinters HV, et al

    . The impact of thromboemboli histology on the performance of a mechanical thrombectomy device. AJNR Am J Neuroradiol 2012;33:643–48 doi:10.3174/ajnr.A2842 pmid:22207297

    Abstract/FREE Full Text
15. 15.↵
    1. Dobrocky T,
    2. Piechowiak E,
    3. Cianfoni A, et al

    . Thrombectomy of calcified emboli in stroke: Does histology of thrombi influence the effectiveness of thrombectomy? J Neurointerv Surg 2018;10:345–50 doi:10.1136/neurintsurg-2017-013226 pmid:28798266

    Abstract/FREE Full Text
16. 16.↵
    1. Duffy S,
    2. Mccarthy R,
    3. Farrell M, et al

    . Per-pass analysis of thrombus composition in patients with acute ischemic stroke undergoing mechanical thrombectomy. Stroke 2019;50:1156–63 doi:10.1161/STROKEAHA.118.023419 pmid:31009342

    CrossRefPubMed
17. 17.↵
    1. Darcourt J,
    2. Garcia C,
    3. Phuong DM, et al

    . Absence of susceptibility vessel sign is associated with aspiration-resistant fibrin/platelet-rich thrombi. Int J Stroke 2021 Jan 12. [Epub ahead of print] doi:10.1177/1747493020986626 pmid:33435860

    CrossRefPubMed
18. 18.↵
    1. Bourcier R,
    2. Volpi S,
    3. Guyomarch B, et al

    . Susceptibility vessel sign on MRI predicts favorable clinical outcome in patients with anterior circulation acute stroke treated with mechanical thrombectomy. AJNR Am J Neuroradiol 2015;36:2346–53 doi:10.3174/ajnr.A4483 pmid:26316570

    Abstract/FREE Full Text
19. 19.↵
    1. Liu M,
    2. Li L,
    3. Li G

    . The different clinical value of susceptibility vessel sign in acute ischemic patients with stroke under different interventional therapy: a systematic review and meta-analysis. J Clin Neurosci 2019;62:72–79 doi:10.1016/j.jocn.2019.01.002 pmid:30712778

    CrossRefPubMed
20. 20.↵
    1. Adams HP,
    2. Bendixen BH,
    3. Kappelle LJ, et al

    . Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial–TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35–41 doi:10.1161/01.str.24.1.35 pmid:7678184

    Abstract/FREE Full Text
21. 21.↵
    1. Liebeskind DS,
    2. Bracard S,
    3. Guillemin F, et al

    ; HERMES Collaborators. ETICI reperfusion: defining success in endovascular stroke therapy. J Neurointerv Surg 2019;11:433–38 doi:10.1136/neurintsurg-2018-014127 pmid:30194109

    Abstract/FREE Full Text
22. 22.↵
    1. Hacke W,
    2. Kaste M,
    3. Fieschi C, et al

    . Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245–51 doi:10.1016/S0140-6736(98)08020-9 pmid:9788453

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Lapergue B,
    2. Blanc R,
    3. Gory B, et al

    ; ASTER Trial Investigators. Effect of endovascular contact aspiration vs stent retriever on revascularization in patients with acute ischemic stroke and large vessel occlusion: the ASTER randomized clinical trial. JAMA 2017;318:443–52 doi:10.1001/jama.2017.9644 pmid:28763550

    CrossRefPubMed
24. 24.↵
    1. Aoki J,
    2. Kimura K,
    3. Shibazaki K, et al

    . Location of the susceptibility vessel sign on T2*-weighted MRI and early recanalization within 1 hour after tissue plasminogen activator administration. Cerebrovasc Dis Extra 2013;3:111–20 doi:10.1159/000354848 pmid:24163686

    CrossRefPubMed
25. 25.↵
    1. Kimura K,
    2. Sakamoto Y,
    3. Aoki J, et al

    . Clinical and MRI predictors of no early recanalization within 1 hour after tissue-type plasminogen activator administration. Stroke 2011;42:3150–55 doi:10.1161/STROKEAHA.111.623207 pmid:21868738

    Abstract/FREE Full Text
26. 26.↵
    1. Hashimoto T,
    2. Hayakawa M,
    3. Funatsu N, et al

    . Histopathologic analysis of retrieved thrombi associated with successful reperfusion after acute stroke thrombectomy. Stroke 2016;47:3035–37 doi:10.1161/STROKEAHA.116.015228 pmid:27780903

    Abstract/FREE Full Text
27. 27.↵
    1. Gunning GM,
    2. Mcardle K,
    3. Mirza M, et al

    . Clot friction variation with fibrin content; implications for resistance to thrombectomy. J Neurointerv Surg 2018;10:34–38 doi:10.1136/neurintsurg-2016-012721 pmid:28044009

    Abstract/FREE Full Text
28. 28.↵
    1. Ruttmann E,
    2. Willeit J,
    3. Ulmer H, et al

    . Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke 2006;37:2094–99 doi:10.1161/01.STR.0000229894.28591.3f pmid:16794213

    Abstract/FREE Full Text
29. 29.↵
    1. Kneihsl M,
    2. Enzinger C,
    3. Wünsch G, et al

    . Poor short-term outcome in patients with ischaemic stroke and active cancer. J Neurol 2016;263:150–56 doi:10.1007/s00415-015-7954-6 pmid:26530513

    CrossRefPubMed
30. 30.↵
    1. Aarnio K,
    2. Joensuu H,
    3. Haapaniemi E, et al

    . Cancer in young adults with ischemic stroke. Stroke 2015;46:1601–06 doi:10.1161/STROKEAHA.115.008694 pmid:25922510

    Abstract/FREE Full Text
31. 31.↵
    1. Fu CH,
    2. Chen CH,
    3. Lin YH, et al

    . Fibrin and platelet-rich composition in retrieved thrombi hallmarks stroke with active cancer. Stroke 2020;51:3723–27 doi:10.1161/STROKEAHA.120.032069 pmid:33138690

    CrossRefPubMed
32. 32.↵
    1. Ye G,
    2. Gao Q,
    3. Qi P, et al

    . The role of diabetes mellitus on the thrombus composition in patients with acute ischemic stroke. Interv Neuroradiol 2020;26:329–36 doi:10.1177/1591019919896940 pmid:31924102

    CrossRefPubMed
33. 33.↵
    1. Meinel TR,
    2. Kaesmacher J,
    3. Mosimann PJ, et al

    . Association of initial imaging modality and futile recanalization after thrombectomy. Neurology 2020;95:e2331–42 doi:10.1212/WNL.0000000000010614 pmid:32847948

    CrossRefPubMed
34. 34.↵
    1. Bang OY,
    2. Saver JL,
    3. Kim SJ, et al

    . Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke 2011;42:693–99 doi:10.1161/STROKEAHA.110.595256 pmid:21233472

    Abstract/FREE Full Text